Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	132.30	89.30	38.44
Graham Fair Price	-57.27	5.56	13.02
PEG	283.66	-0.66	0.17
Price/Book	-17.23	5.15	6.22
Price/Cash Flow	-7.67	-26.52	28.72
Prices/Earnings	266.82	52.49	14.31
Price/Sales	12.67	9.75	8.65
Price/FCF	-7.67	-26.52	28.72
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.90	0.57	0.61
Operating Margin	-59.95	0.08	0.19
ROA	-75.61	0.01	0.06
ROE	0.11	0.02	-77.43
ROIC	0.09	0.02	-75.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.10	-93.04
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.59	-0.74	25.71
EPS QOQ	0.84	-0.80	-4.39
FCF QOQ	1.63	-1.80	10.80
Revenue QOQ	0.20	-0.34	72.56
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	148.36	223.44	50.61
Days Sales Outstanding (DSO)	16.58	28.56	72.25
Inventory Turnover	0.61	0.40	-33.60
Debt/Capitalization	0.12	0.21	80.82
Quick Ratio	1.34	0.94	-29.62
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.33	7.49	-10.06
Cash	5.05	2.01	-60.14
Capex	-0.17	-0.25	-50.91
Free Cash Flow	1.80	-1.45	-19.37
Revenue	5.98	3.95	-33.92
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.30	2.35	2.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.39	0.03	-98.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating